Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01807325 · ClinicalTrials.gov registry record
RNA Sequencing of Solid and Cystic Lesions of the Pancreas
A clinical trial, sponsored by Oregon Health and Science University.
- Completed
- Registry status
- 72
- Enrollment target
NCT01807325 is a clinical trial that has completed, run by Oregon Health and Science University. The registered enrollment target is 72 participants.
The verdict
NCT01807325 has completed, sponsored by Oregon Health and Science University.
- COMPLETED
- Registry status
- 72 participants
- Enrollment target
Study Summary
The nature of cysts and solid masses in the pancreas can be difficult to diagnose. They may be benign, precancerous, or cancer. Current tests such as cytology (looking under a microscope) and tumor markers do not always give us the answer. The investigators are looking for genetic markers on biopsy specimens from the pancreas that will give us a better test for diagnosis. This study is only for diagnosing these lesions. The investigators are not treating any patients.
Interventions
- PROCEDURE pancreas biopsy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 72 participants |
| Start Date | 2012-12 |
| Est. Completion | 2019-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01807325
The ClinicalTrials.gov registry entry for NCT01807325 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 72 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Oregon Health and Science University, which has 546 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which pancreas biopsy is the first listed.
NCT01807325 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01807325 about?
NCT01807325 is a clinical study titled "RNA Sequencing of Solid and Cystic Lesions of the Pancreas". The nature of cysts and solid masses in the pancreas can be difficult to diagnose. They may be benign, precancerous, or cancer. Current tests such as cytology (looking under a microscope) and tumor markers do not always give us the answer. The investigators are looking for genetic markers on biopsy ...
What is the current status of trial NCT01807325?
This trial is currently completed. The enrollment target is 72 participants. The study started on 2012-12. Estimated completion is 2019-12.
What interventions are being tested in trial NCT01807325?
The interventions under investigation include: pancreas biopsy (PROCEDURE).
Who is sponsoring clinical trial NCT01807325?
This trial is sponsored by Oregon Health and Science University, which has 546 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.